Author: Mohamed Abdel-Kareem

    1. POLARISqb Secures DARPA Funding to Propel Quantum Computing Applications in Drug Design

      POLARISqb has been awarded a research contract by the Defense Advanced Research Project Agency (DARPA) under the IMPAQT initiative to advance quantum computing applications in drug design. Building upon their pioneering work in quantum-enabled drug discovery, POLARISqb aims to develop novel methods targeting protein-protein interactions (PPIs), a challenging aspect of drug design crucial for addressing emerging threats like the Ebola virus and persistent ailments like cancer. The project will focus on creating a variational quantum algorithm (VQA) capable of identifying small molecules that modulate PPIs, leveraging the unique capabilities of quantum computing to navigate vast solution spaces inaccessible to classical methods.